Tesamorelin ipamorelin blend cost: Frequently asked questions

Source peptides during promotional periods and store unopened lyophilized vials at –20°C for up to 24 months. Bulk purchasing three months of supply during a discount window reduces per-vial cost by 12–18% compared to monthly reorders. Reconstituted peptides must be used within 28 days when stored at 2–8°C, but unopened lyophilized powder remains stable for years under proper freezing conditions. This strategy works only if you're committed to a consistent protocol. Purchasing six vials of a blend you'll need to adjust in two months creates waste, not savings.

Switch suppliers immediately. A certificate of analysis (COA) from an independent third-party lab using HPLC or mass spectrometry is the only verification that the peptide you're injecting matches the advertised purity and sequence. Peptides synthesized without batch verification can contain amino acid substitutions, truncated sequences, or synthesis byproducts that range from inactive to potentially harmful. Paying $40–$60 less per vial for unverified peptides isn't cost savings. It's paying to inject an unknown substance. Every peptide at Real Peptides includes third-party COA documentation with exact purity percentages and sequencing confirmation.

Budget an additional $25–$45 for a portable insulin cooler or FRIO wallet that maintains 2–8°C without electricity or ice packs. Reconstituted Tesamorelin + Ipamorelin blends must stay refrigerated continuously. Temperature excursions above 8°C for more than four hours cause irreversible peptide denaturation that neither appearance nor at-home testing can detect. Standard TSA regulations allow insulin coolers in carry-on luggage; declare them at security but expect no issues. For trips longer than five days, consider pausing your protocol rather than risking temperature-related degradation that turns functional peptides into expensive saline.

Order separate Tesamorelin and Ipamorelin vials rather than fixed-ratio blends. Dose escalation typically increases Tesamorelin from 2mg to 3–4mg daily between weeks 8–12 while holding Ipamorelin constant at 300mcg nightly. A fixed blend forces you to increase both peptides proportionally or waste unused Ipamorelin. Separate vials cost 15–25% more upfront ($321–$428 vs $281–$358 monthly) but eliminate waste when only one peptide's dose changes. Budget an additional $80–$120 for the second Tesamorelin vial during escalation months.

HPLC alone confirms purity percentage and molecular weight but cannot detect single-amino-acid substitutions or positional isomers—both of which occur at low frequency (0.5–2%) even in competent synthesis. For Tesamorelin, a 44-residue peptide, the probability of at least one positional error in a batch is non-trivial without sequence-level verification. Request mass spec data for at least one representative batch per lot. Suppliers confident in their synthesis quality provide this readily; resistance to the request is itself a data point about process control.

Purchase larger total quantities per order to amortise per-batch verification costs, then aliquot and store at −80°C in single-use portions. Lyophilised peptides stored in sealed vials under inert atmosphere at −80°C remain stable for 24–36 months without measurable degradation. Buying quarterly instead of monthly reduces per-milligram cost by 15–25% at most suppliers while maintaining full verification standards. Reconstitute only what you will use within 7–10 days; reconstituted peptide solutions degrade meaningfully faster than lyophilised powder even under refrigeration.

Use UV-absorbance-verified peptides only for preliminary dose-finding or proof-of-concept work, not for data intended for publication. The 8–12% purity variance observed in budget-tier peptides introduces coefficient-of-variation increases large enough to obscure treatment effects in studies with modest effect sizes. If your research protocol spans more than four weeks or requires dose-response curve construction, the cost savings from budget sourcing are statistically likely to be offset by the need to re-run experiments with tighter-variance peptides.